Covid-19 boosters should start with most vulnerable, says WHO

Last year, WHO pleaded with rich countries to declare a moratorium on offering booster doses until the end of 2021

World Health Organisation, WHO
AP Geneva
2 min read Last Updated : Jan 21 2022 | 9:16 PM IST

The World Health Organisation says that coronavirus vaccine boosters should now now be offered to people, starting with the most vulnerable, in a move away from its previous insistence that boosters were unnecessary for healthy adults and an acknowledgment that the vaccine supply is improving globally.

At a press briefing on Friday, the UN health agency said it was now recommending booster doses of the Pfizer-BioNTech vaccine, beginning in the highest-priority groups, about four to six months after receiving the first two doses, in line with guidance from dozens of countries that embarked upon booster programs months ago.

Last year, WHO pleaded with rich countries to declare a moratorium on offering booster doses until the end of 2021, an appeal that went almost entirely ignored.

The agency said its expert vaccine group assessed the increasing data about booster doses and noted the waning of immune protection over time. Numerous studies have shown in recent months that booster doses restore antibody levels and offer strong protection against severe disease, including against COVID-19 variants like delta and omicron.

Boosters are part of the vaccination program, but it doesn't mean unfettered use to all ages, said WHO's Dr Kate O'Brien, director of immunisation, vaccines and biologicals. We continue to have highest focus on vaccination of highest priority groups, she said.

WHO also endorsed the use of the Pfizer-BioNTech vaccine for children as young as 5, at a reduced dose. Countries including the US and Canada gave the green light to Pfizer's shot for young children last fall.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineWHO

First Published: Jan 21 2022 | 9:16 PM IST

Next Story